United States · FDA National Drug Code directory
EVEROLIMUS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72603-254_10865ecf-d37f-4062-ec4e-b8c8a9c36897
- Product NDC
- 72603-254
- Form
- TABLET
- Composition / generic term
- everolimus
- Labeler
- NorthStar RxLLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241001
- Source listing expiry
- 20271231
Source-listed ingredients
- EVEROLIMUS — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (72603-254-01) · 72603-254-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →